1. Aibar-Almazán A, Voltes-Martínez A, Castellote-Caballero Y, Afanador-Restrepo D, Carcelén-Fraile M, López-Ruiz E. Current Status of the Diagnosis and Management of Osteoporosis. Int J Mol Sci. 2022;23 (16):9465. [DOI:10.3390/ijms23169465] [PMID] []

2. Akkawi I, Zmerly H. Osteoporosis: Current Concepts. . Joints. 2018;6 (2):122-7. [DOI:10.1055/s-0038-1660790] [PMID] []

3. Sinaki M. Osteoporosis. Braddom's Physical Medicine and Rehabilitation. 2021;6:690-714.e3. [DOI:10.1016/B978-0-323-62539-5.00034-5]

4. De Martinis M, Sirufo M, Polsinelli M, Placidi G, Di Silvestre D, Ginaldi L. Gender Differences in Osteoporosis: A Single-Center Observational Study. World J Mens Health. 2021;39 (4):750-9. [DOI:10.5534/wjmh.200099] [PMID] []

5. Noirrit-Esclassan E, Valera M-C, Tremollieres F, Arnal J-F, Lenfant F, Fontaine C, et al. Critical Role of Estrogens on Bone Homeostasis in Both Male and Female: From Physiology to Medical Implications. International Journal of Molecular Sciences. 2021;22 (4):1568. [DOI:10.3390/ijms22041568] [PMID] []

6. Lobo R, Gompel A. Management of menopause: a view towards prevention. The Lancet Diabetes & Endocrinology. 2022;10 (6):457-70. [DOI:10.1016/S2213-8587(21)00269-2] [PMID]

7. Shen Y, Huang X, Wu J, Lin X, Zhou X, Zhu Z, et al. The Global Burden of Osteoporosis, Low Bone Mass, and Its Related Fracture in 204 Countries and Territories, 1990-2019. Front Endocrinol (Lausanne). 2022;13:882241. [DOI:10.3389/fendo.2022.882241] [PMID] []

8. Willers C, Norton N, Harvey N, Jacobson T, Johansson H, Lorentzon M, et al. SCOPE review panel of the IOF. Osteoporosis in Europe: a compendium of country-specific reports. Arch Osteoporos. 2022;17 (1):23. [DOI:10.1007/s11657-021-00969-8] [PMID] []

9. Asavamongkolkul A, Adulkasem N, Chotiyarnwong P, Vanitcharoenkul E, Chandhanayingyong C, Laohaprasitiporn P, et al. Prevalence of osteoporosis, sarcopenia, and high falls risk in healthy community-dwelling Thai older adults: a nationwide cross-sectional study. JBMR Plus. 2024;8 (2):20. [DOI:10.1093/jbmrpl/ziad020] [PMID] []

10. Fahimfar N, Noorali S, Yousefi S, Gharibzadeh S, Shafiee G, Panahi N, et al. Prevalence of osteoporosis among the elderly population of Iran. Arch Osteoporos. 2021;16 (1):16. [DOI:10.1007/s11657-020-00872-8] [PMID]

11. Fallahi A, Valiee S, Chan SW. Needs of Women with Osteoporosis in Disease Self-Management: A Qualitative Study. Health Scope. 2019;8 (2):e57234. [DOI:10.5812/jhealthscope.57234]

12. Cosman F, De Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S, et al. Clinician's guide to prevention and treatment of osteoporosis. Osteoporosis international. 2014;25 (10):2359-81. [DOI:10.1007/s00198-014-2794-2] [PMID] []

13. LeBoff M, Greenspan S, Insogna K, Lewiecki E, Saag K, Singer A, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33 (10):2049-102. [DOI:10.1007/s00198-021-05900-y] [PMID] []

14. Morell S, Hemmeler C, Amsler F, Gross T. Adherence to osteoporosis pharmacotherapy one year after osteoporotic fracture-a Swiss trauma center secondary prevention project. Swiss medical weekly. 2017;147:w14451-w. [DOI:10.4414/smw.2017.14451] []

15. Mangano G, Avola M, Blatti C, Caldaci A, Sapienza M, Chiaramonte R, et al. Non-Adherence to Anti-Osteoporosis Medication: Factors Influencing and Strategies to Overcome It: A Narrative Review. Journal of Clinical Medicine. 2023;12 (1):14. [DOI:10.3390/jcm12010014] [PMID] []

16. Peh K, Kwan Y, Goh H, Ramchandani H, Phang J, Lim Z, et al. An Adaptable Framework for Factors Contributing to Medication Adherence: Results from a Systematic Review of 102 Conceptual Frameworks. J Gen Intern Med. 2021;36 (9):2784-95. [DOI:10.1007/s11606-021-06648-1] [PMID] []

17. Mashrouteh M, Khanjani N, Gozashti MH. Evaluation of Compliance with Drug Regimens in Diabetic Patients Referred to the Endocrinology Clinic of Afzalipour Hospital, Kerman, Iran. Journal of Health and Development. 2012;1 (3):182-92.

18. Laius O, Pisarev H, Maasalu K, Kõks S, Märtson A. Adherence to osteoporosis medicines in Estonia-a comprehensive 15-year retrospective prescriptions database study. Archives of osteoporosis. 2017;12 (1):59. [DOI:10.1007/s11657-017-0354-z] [PMID]

19. Seyed Fatemi N RF, Hajizadeh E, Modanloo M. Psychometric properties of the adherence questionnaire in patients with chronic disease: A mix method study. koomesh Journal. 2018;20 (2):179-91.

20. Dargahi A, Zamani Z, Vosoughi Niri M, Zandian H, Hamidzadeh Arbabi Y. Explaining the Reasons for the General Public's Non-compliance With the Policies of the National Anti-Coronavirus Headquarters: A Qualitative Study. Health in Emergencies and Disasters Quarterly. 2022;7 (3):145-60. [DOI:10.32598/hdq.7.3.445.1]

21. Foley L, Larkin J, Lombard-Vance R, Murphy A, Hynes L, Galvin E, et al. Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open. 2021;11 (9):e044987. [DOI:10.1136/bmjopen-2020-044987] [PMID] []

22. Vargas Negrín F. Adherencia al tratamiento: un reto difícil pero posible. Revista de Osteoporosis y Metabolismo Mineral. 2014;6 (1):5-7. [DOI:10.4321/S1889-836X2014000100002]

23. Paskins Z, Babatunde O, Sturrock A, Toh L, Horne R, Maidment I. Effectiveness Working Group of the Royal Osteoporosis Society Osteoporosis, Bone Research Academy. Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance. Osteoporos Int. 2022;33 (11):2245-57. [DOI:10.1007/s00198-022-06453-4] [PMID] []

24. Seyed Fatemi N RF HE, Modanlou MD. Psychometric properties of the adherence questionnaire in patients with chronic disease: A mix method study. 2018;20 (20):179-91.

25. Huang C, Shiao M, Mao T. Retrospective Analysis of the Effects of Non-Compliance with Denosumab on Changes in Bone Mineral Density During the COVID-19 Pandemic. Patient Prefer Adherence. 2021;15:1579-84. [DOI:10.2147/PPA.S316144] [PMID] []

26. Gholamaliei B, Karimi-Shahanjarini A, Roshanaei G, Rezapur-, Shahkolai F. Medication Adherence and its Related Factors in Patients with Type II Diabetes. Journal of Education and Community Health. 2016;2 (9). [DOI:10.21859/jech-02042]

27. Orimo H, Sato M, Kimura S, Wada K, Chen X, Yoshida S, et al. Understanding the factors associated with initiation and adherence of osteoporosis medication in Japan: An analysis of patient perceptions. Osteoporosis and Sarcopenia. 2017;3 (4):174-84. [DOI:10.1016/j.afos.2017.10.002] [PMID] []

28. Mathes T, Jaschinski T, Pieper D. Adherence influencing factors-a systematic review of systematic reviews. Archives of Public Health. 2014;72 (1):37. [DOI:10.1186/2049-3258-72-37] [PMID] []

29. Nho J-H, Lee Y-K, Ha Y-C, Kim C-H, Suh Y-S, Koo K-H. Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis? Journal of bone metabolism. 2016;23 (2):51-4. [DOI:10.11005/jbm.2016.23.2.51] [PMID] []

30. Salari N, Ghasemi H, Mohammadi L, Behzadi M, Rabieenia E, Shohaimi S, et al. The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16 (1):609. [DOI:10.1186/s13018-021-02772-0] [PMID] []

31. Panahi R, Hosseini N, Yavari S, Javanmardi K, Amjadian M. Relationship between health literacy skills and walking behavior to prevent osteoporosis among health volunteers. J Prev Med Hyg. 2023;64 (1):E48-E54.

32. Reynolds K, Viswanathan HN, D O'Malley C, Muntner P, Harrison TN, Cheetham TC, et al. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates. Annals of Pharmacotherapy. 2012;46 (5):659-70. [DOI:10.1345/aph.1Q652] [PMID]

33. Schunk D, DiBenedetto M. Chapter Four - Self-efficacy and human motivation Advances in Motivation Science. 2021;8:153-79. [DOI:10.1016/bs.adms.2020.10.001]

34. Iversen MD, Vora RR, Servi A, Solomon DH. Factors affecting adherence to osteoporosis medications: a focus group approach examining viewpoints of patients and providers. Journal of geriatric physical therapy (2001). 2011;34 (2):72.

35. Breuil V, Cortet B, Cotté F-E, Arnould B, Dias-Barbosa C, Gaudin A-F, et al. Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. Osteoporosis International. 2012;23 (2):445-55. [DOI:10.1007/s00198-011-1555-8] [PMID] []

36. Avci IA. Factors associated with breast self-examination practices and beliefs in female workers at a Muslim community. European journal of oncology nursing. 2008;12 (2):127-33. [DOI:10.1016/j.ejon.2007.11.006] [PMID]

37. Zareban I, Fallahi A, Nemat-Shahrbabaki B, P P. Determinants of treatment adherence among women with osteoporosis: A qualitative study in Iran. Health Educ Health Promot. 2019;7 (1):27-33. [DOI:10.29252/HEHP.7.1.27]

38. Cadarette SM, Burden AM. Measuring and improving adherence to osteoporosis pharmacotherapy. Current opinion in rheumatology. 2010;22 (4):397. [DOI:10.1097/BOR.0b013e32833ac7fe] [PMID] []

39. Petrova G, Todorova A, Georgiev T, Petkova-Gueorguieva E, Mihaylova A, Peikova L, et al. Assessment of patients' awareness on drugs use and adherence to drug therapy as an element of Medication Review service. Pharmacia. 2023;70 (3):595-601. [DOI:10.3897/pharmacia.70.e109838]

40. Flood EM, Beusterien KM, Green H, Shikiar R, Baran RW, Amonkar MM, et al. Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q™), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women. Health and Quality of Life Outcomes. 2006;4 (1):42. [DOI:10.1186/1477-7525-4-42] [PMID] []

41. Maunder L. Motivating people to stay at home: using the Health Belief Model to improve the effectiveness of public health messaging during the COVID-19 pandemic. Transl Behav Med. 2021;11 (10):1957-62. [DOI:10.1093/tbm/ibab080] [PMID] []

42. Kumar A, Mohammadnezhad M, May W. Patients' Perception of Factors Influencing Noncompliance with Medication among Cardiac Patients in Fiji: A Qualitative Study. Patient Prefer Adherence. 2021;15:1843-52. [DOI:10.2147/PPA.S322731] [PMID] []

43. Kishimoto H, Maehara M. Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA. Archives of osteoporosis. 2015;10 (1):27. [DOI:10.1007/s11657-015-0231-6] [PMID] []

44. Pourhabibi N, Mohebbi B, Sadeghi R, Shakibazadeh E, Sanjari M, Tol A, et al. Determinants of Poor Treatment Adherence among Patients with Type 2 Diabetes and Limited Health Literacy: A Scoping Review. J Diabetes Res. 2022;6:2980250. [DOI:10.1155/2022/2980250] [PMID] []